Mark Edward Randall - Nov 30, 2022 Form 4/A - Amendment Insider Report for TC BioPharm (Holdings) plc (TCBP)

Role
10%+ Owner
Signature
/s/ Thomas Nicholls
Stock symbol
TCBP
Transactions as of
Nov 30, 2022
Transactions value $
$350,000
Form type
4/A - Amendment
Date filed
1/11/2023, 03:09 PM
Date Of Original Report
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCBP Ordinary Shares [ADS] Purchase $350K +70K +104.74% $5.00* 137K Nov 30, 2022 By Renaissance Capital Partners Ltd
holding TCBP Ordinary Shares [ADS] 9.95K Nov 30, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCBP Series A Warrants Purchase $0 +70K $0.00 70K Nov 30, 2022 Ordinary Shares 70K $5.00 By Renaissance Capital Partners Ltd F1
transaction TCBP Series B Warrants Purchase $0 +70K $0.00 70K Nov 30, 2022 Ordinary Shares 70K $5.00 By Renaissance Capital Partners Ltd F2
holding TCBP Warrants 106K Nov 30, 2022 Ordinary Shares 106K $4.25 By Renaissance Capital Partners Ltd
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Series A Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.
F2 Series B Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.